RecruitingNCT03683251
Extension Study for the Port Delivery System With Ranibizumab (Portal)
PHASE3 · 1,000 planned enrolment
- Countries listed
- 15
- Registry update
- September 28, 2026
immortal.lifeExact source-linked program identifier and related public trial registrations.
1 exact source-linked registration. No aliases, synonyms, ownership, or cross-source equivalence are inferred.
PHASE3 · 1,000 planned enrolment